Search Results
Search for other papers by Liting Wu in
Google Scholar
PubMed
Search for other papers by Li Xiong in
Google Scholar
PubMed
Department of Geriatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Search for other papers by Jin Li in
Google Scholar
PubMed
Search for other papers by Zishan Peng in
Google Scholar
PubMed
Search for other papers by Luyao Zhang in
Google Scholar
PubMed
Search for other papers by Peijie Shi in
Google Scholar
PubMed
Department of Geriatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Search for other papers by Yingying Gong in
Google Scholar
PubMed
Search for other papers by Haipeng Xiao in
Google Scholar
PubMed
and disease ( Zhang et al. 2013 , 2018 b , Du et al. 2016 , 2017 ). In diabetes, circHIPK3 and CDR1as have been shown to regulate β-cell proliferation and insulin secretion in mouse islets by sponging multiple miRNA and modulating the activity
Molecular Physiology and Biophysics and
Program in Developmental Biology, Vanderbilt University Medical Center, 2220 Pierce Avenue 746 PRB, Nashville, Tennessee 37232, USA
Search for other papers by Amanda M Ackermann in
Google Scholar
PubMed
Molecular Physiology and Biophysics and
Program in Developmental Biology, Vanderbilt University Medical Center, 2220 Pierce Avenue 746 PRB, Nashville, Tennessee 37232, USA
Search for other papers by Maureen Gannon in
Google Scholar
PubMed
by β-cell neogenesis (differentiation from precursor cells), β-cell proliferation, and β-cell hypertrophy (increased cell size), and is decreased by β-cell death, primarily through apoptosis, and β-cell atrophy (decreased cell size; Fig. 3 ). From
Search for other papers by M Blandino-Rosano in
Google Scholar
PubMed
Search for other papers by G Perez-Arana in
Google Scholar
PubMed
Search for other papers by J M Mellado-Gil in
Google Scholar
PubMed
Search for other papers by C Segundo in
Google Scholar
PubMed
Search for other papers by M Aguilar-Diosdado in
Google Scholar
PubMed
et al . 2001 ) and diet-inducing hyperglycemia has been shown to be associated with a transient proliferative response ( Donath et al . 1999 ). However, no increased β-cell proliferation has been observed associated with the recent onset of DM1 in
Search for other papers by Jianling Xie in
Google Scholar
PubMed
Search for other papers by Norhan M El Sayed in
Google Scholar
PubMed
Search for other papers by Cheng Qi in
Google Scholar
PubMed
Search for other papers by Xuechan Zhao in
Google Scholar
PubMed
Search for other papers by Claire E Moore in
Google Scholar
PubMed
Search for other papers by Terence P Herbert in
Google Scholar
PubMed
investigate how exendin-4 stimulates β-cell proliferation. To these ends, we have demonstrated, in rat islets of Langerhans, that in the presence of glucose, exendin-4 acutely activates mTORC1 via the autocrine/paracrine activation of the IGF1R, whereas EGFR
Department of Pharmacology, Novo Nordisk A/S, Bagsværd, Denmark
Steno Diabetes Center, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark
Institute of Medical Biochemistry and Genetics, Panum Institute, University of Copenhagen, Denmark
Search for other papers by K Lindberg in
Google Scholar
PubMed
Department of Pharmacology, Novo Nordisk A/S, Bagsværd, Denmark
Steno Diabetes Center, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark
Institute of Medical Biochemistry and Genetics, Panum Institute, University of Copenhagen, Denmark
Search for other papers by S G Rønn in
Google Scholar
PubMed
Department of Pharmacology, Novo Nordisk A/S, Bagsværd, Denmark
Steno Diabetes Center, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark
Institute of Medical Biochemistry and Genetics, Panum Institute, University of Copenhagen, Denmark
Search for other papers by D Tornehave in
Google Scholar
PubMed
Department of Pharmacology, Novo Nordisk A/S, Bagsværd, Denmark
Steno Diabetes Center, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark
Institute of Medical Biochemistry and Genetics, Panum Institute, University of Copenhagen, Denmark
Search for other papers by H Richter in
Google Scholar
PubMed
Department of Pharmacology, Novo Nordisk A/S, Bagsværd, Denmark
Steno Diabetes Center, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark
Institute of Medical Biochemistry and Genetics, Panum Institute, University of Copenhagen, Denmark
Search for other papers by J A Hansen in
Google Scholar
PubMed
Department of Pharmacology, Novo Nordisk A/S, Bagsværd, Denmark
Steno Diabetes Center, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark
Institute of Medical Biochemistry and Genetics, Panum Institute, University of Copenhagen, Denmark
Search for other papers by J Rømer in
Google Scholar
PubMed
Department of Pharmacology, Novo Nordisk A/S, Bagsværd, Denmark
Steno Diabetes Center, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark
Institute of Medical Biochemistry and Genetics, Panum Institute, University of Copenhagen, Denmark
Search for other papers by M Jackerott in
Google Scholar
PubMed
Department of Pharmacology, Novo Nordisk A/S, Bagsværd, Denmark
Steno Diabetes Center, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark
Institute of Medical Biochemistry and Genetics, Panum Institute, University of Copenhagen, Denmark
Search for other papers by N Billestrup in
Google Scholar
PubMed
shown to be important growth factors for the β-cell as they stimulate insulin synthesis as well as β-cell proliferation ( Nielsen 1982 , 1985 , Nielsen et al. 1992 , Brelje et al. 1993 ). Specific receptors for both PRL and GH are present on β
AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK
Search for other papers by Kay E Garnett in
Google Scholar
PubMed
AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK
Search for other papers by Philip Chapman in
Google Scholar
PubMed
AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK
Search for other papers by Julie A Chambers in
Google Scholar
PubMed
AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK
Search for other papers by Ian D Waddell in
Google Scholar
PubMed
AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK
Search for other papers by David S W Boam in
Google Scholar
PubMed
Egr-1 expression is strikingly enriched in islets and that its small interfering RNA (siRNA)-mediated silencing inhibits β-cell proliferation. Taken together, these findings suggest a significant role for Egr-1 in β-cell proliferation
Department of Anesthesiology, The First People’s Hospital of Foshan & Foshan Hospital of Sun Yat-sen University, Guangdong, China
Search for other papers by Xianjie Wen in
Google Scholar
PubMed
Search for other papers by Yisheng Yang in
Google Scholar
PubMed
secretion per se in Glis3 − / − mice. GLIS3 is required for obesity-induced β cell proliferation and mass expansion In states of insulin resistance, such as obesity and pregnancy, the expansion of β cell mass in accordance with the requirements
Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism
Search for other papers by Riccarda Granata in
Google Scholar
PubMed
Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism
Search for other papers by Alessandra Baragli in
Google Scholar
PubMed
Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism
Search for other papers by Fabio Settanni in
Google Scholar
PubMed
Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism
Search for other papers by Francesca Scarlatti in
Google Scholar
PubMed
Search for other papers by Ezio Ghigo in
Google Scholar
PubMed
. 2010 ). Both AG and UAG promote HIT-T15 and INS-1E β-cell proliferation, and inhibit apoptotic events induced by serum starvation and treatment with cytokines ( Granata et al . 2006 , 2007 ), a major cause of β-cell loss particularly in type 1
Departamento de Bioquímica y Biología Molecular II, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Departamento de Metabolismo y Nutrición, Facultad de Farmacia, Universidad Complutense de Madrid, UCM, 28040 Madrid, Spain
Search for other papers by Laura de Miguel-Santos in
Google Scholar
PubMed
Search for other papers by Elisa Fernández-Millán in
Google Scholar
PubMed
Departamento de Bioquímica y Biología Molecular II, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Departamento de Metabolismo y Nutrición, Facultad de Farmacia, Universidad Complutense de Madrid, UCM, 28040 Madrid, Spain
Search for other papers by María Ángeles Martín in
Google Scholar
PubMed
Departamento de Bioquímica y Biología Molecular II, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Departamento de Metabolismo y Nutrición, Facultad de Farmacia, Universidad Complutense de Madrid, UCM, 28040 Madrid, Spain
Search for other papers by Fernando Escrivá in
Google Scholar
PubMed
Departamento de Bioquímica y Biología Molecular II, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Departamento de Metabolismo y Nutrición, Facultad de Farmacia, Universidad Complutense de Madrid, UCM, 28040 Madrid, Spain
Search for other papers by Carmen Álvarez in
Google Scholar
PubMed
al . 1997 ), associated to the stimulation of β-cell proliferation due to locally increased pancreatic IGF-1 and islet IRS-2 production ( Martín et al . 2005 , Fernández et al . 2007 ). Nevertheless, food restriction continued after birth induced a
Search for other papers by Maria Sörhede Winzell in
Google Scholar
PubMed
Search for other papers by Bo Ahrén in
Google Scholar
PubMed
studies have suggested that GLP-1 receptor activation inhibits islet apoptosis and stimulates β-cell proliferation ( Xu et al . 1999 , Perfetti et al . 2000 , Stoffers et al . 2000 , Wang & Brubaker 2002 , Egan et al . 2003 , Li et al . 2003